FDA concerns with unapproved GLP-1 drugs used for weight loss
Although its generally harmless and short-lived, orthostatic hypotension can sometimes cause people to faint and some individuals experience it routinely, which affects their daily function
64 Taken together, the current body of evidence suggests that while early observational signals raised concern, more robust and contemporary data do not demonstrate a consistent or clinically meaningful increase in pancreatitis risk associated with GLP-1 RA therapy
In this regard, seminal plasma from RPM-treated rams showed higher expression of the microRNA miR-543-3p, which targets the ten-eleven translocation (TET) family of enzymes responsible for DNA demethylation (Townsend et al., 2025)
Dry mouth, dehydration, ketosis, digestive changes, and reduced food or water intake can all affect breath odor
Abstract# 1413680: post-bariatric hypoglycemia (PBH) refractory to conventional therapies: the combined effect of very high doses of glucagon-like receptor agonist (GLP1-RA) and a low dose of sodium-glucose cotransporter-2 inhibitor (SGLT2i)